Anti-cancer AI tools developer Lunit gets $61m pre-IPO funding round

Fri, November 26, 2021

AltAssets

Cancer-fighting AI developer Lunit has picked up a $61m pre-IPO financing round from investors including HealthQuest Capital and Casdin Capital.

Full article